| Edward R. Hammond |
Edward R. Hammond is currently the Chief Medical Officer at Anavex Life Sciences Corp. |
| Walter E. Kaufmann |
Walter E. Kaufmann is currently the Chief Scientific Officer at Anavex Life Sciences Corp. He previously held positions as the Director-Center for Translational Research at Greenwood Genetic Center, Inc., and as a Professor at Harvard Medical School and The Johns Hopkins University School of Medicine. |
| Stephan Toutain |
Stephan Toutain is currently the Senior Vice President-Operations at Anavex Life Sciences Corp. He previously worked as the General Manager at Alexion Pharmaceuticals, Inc. from 2009 to 2011, Head-Global Commercial Development at Sarepta Therapeutics, Inc. from 2014 to 2015, and Chief Commercial Officer at Interleukin Genetics, Inc. from 2016 to 2017. He has a graduate degree from Nancy-Université and an MBA from The University of North Carolina at Charlotte. |
| Sandra Boenisch |
Sandra Boenisch is currently the Principal Financial Officer & Treasurer at Anavex Life Sciences Corp. She previously worked as the Chief Financial Officer & Treasurer at Destiny Media Technologies, Inc. from 2017 to 2019 and as a Manager-Audit Assurance at BDO Canada LLP from 2008 to 2012. Ms. Boenisch obtained an undergraduate degree from the University of Laurentian. |
| Christopher U. Missling |
Christopher U. Missling is currently the President, CEO, Secretary & Director at Anavex Life Sciences Corp. He previously held positions as the Chief Financial Officer at ImmunoGen, Inc., CFO & Senior Vice President-Strategic Operations at Curis, Inc., Head-Financial Planning at Aventis, Inc., and Head-Healthcare Investment Banking at Brimberg & Co. He has a graduate and doctorate degree from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and another MBA from Kellogg School of Management. |
| Jiong Ma |
Jiong Ma has founded Onetta, Inc. in 2000. She is currently the Chairman at Anavex Life Sciences Corp., an Independent Director at Linkinvax SA, an Independent Director at SES AI Corp., a Director at Clay Merger Sub II, Inc., and an Advisor at Energy Foundry. Dr. Ma's former positions include President, Chief Executive Officer & Director at Chavant Capital Acquisition Corp., Director at Carbonite LLC, Director at Convey Computer Corp., Director at Laser Light Engines, Inc., Director at MC10, Inc., Director at Storiant, Inc., Director at Rohm Powervation Ltd., Director at Fulham Co., Inc., Director at Aledia SAS, Director at Voxel8, Inc., Director at Lo3 Energy, Inc., Director at Powervation, Inc., Independent Director at Mobix Labs, Inc., Principal at Lucent Technologies, Inc., Member-Technical Staff at Nortel Networks, Inc., and Senior Partner at Braemar Energy Ventures from 2008 to 2020. Dr. Ma's education includes a graduate degree from Worcester Polytechnic Institute, an undergraduate degree from Lanzhou University, a graduate degree from Worchester Polytechnic Institute, and a doctorate degree from the University of Colorado Boulder. |
| Athanasios Skarpelos |
Athanasios Skarpelos is an Independent Director and founder of Anavex Life Sciences Corp, which was founded in 2004. |
| Claus van der Velden |
Claus van der Velden is currently the Co-Managing Director at NetCologne Gesellschaft für Telekommunikation mbH and an Independent Director at Anavex Life Sciences Corp. He previously worked as the Director-Corporate Business at Cognis Corp. from 2008 to 2010 and as the Head-Internal Audit & Risk Management at Ströer SE & Co. KGaA from 2011 to 2021. Dr. van der Velden received his undergraduate degree from the University of Kiel and his doctorate from WHU-Otto Beisheim School of Management. |
| Peter Donhauser |
Peter Donhauser is an Independent Director at Anavex Life Sciences Corp. since 2017. He was a Member at European Register For Osteopathic Physicians. He completed his undergraduate degree at Ludwig-Maximilians-Universität München and his doctorate at Philadelphia College of Osteopathic Medicine. |
| Steffen Thomas |
Steffen Thomas is an Independent Director at Anavex Life Sciences Corp. He previously worked as an Attorney at Takeda Pharmaceutical Co., Ltd. and Epping Hermann Fischer Patentanwaltsgesellschaft mbH. Dr. Thomas holds a graduate and doctorate degree from Ludwig-Maximilians-Universität München. |
